These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 24355260)

  • 1. Thoracic tumor effects on plasmatic coagulation: role of hemeoxygenase-1.
    Nielsen VG; Gharagozloo F; Matika RW; Kim S; Zelman EA; Steinbrenner EB
    Lung Cancer; 2014 Feb; 83(2):288-91. PubMed ID: 24355260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasmatic hypercoagulation in patients with breast cancer: role of heme oxygenase-1.
    Nielsen VG; Ley ML; Waer AL; Alger PW; Matika RW; Steinbrenner EB
    Blood Coagul Fibrinolysis; 2013 Dec; 24(8):809-13. PubMed ID: 24145726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brain tumors enhance plasmatic coagulation: the role of hemeoxygenase-1.
    Nielsen VG; Lemole GM; Matika RW; Weinand ME; Hussaini S; Baaj AA; Steinbrenner EB
    Anesth Analg; 2014 May; 118(5):919-24. PubMed ID: 24413553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Colon and pancreas tumors enhance coagulation: role of hemeoxygenase-1.
    Nielsen VG; Nfonsam VN; Matika RW; Ong ES; Jie T; Warneke JA; Steinbrenner EB
    Blood Coagul Fibrinolysis; 2014 Jul; 25(5):435-8. PubMed ID: 24509340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemodialysis patients have plasmatic hypercoagulability and decreased fibrinolytic vulnerability: role of carbon monoxide.
    Matika RW; Nielsen VG; Steinbrenner EB; Sussman AN; Madhrira M
    ASAIO J; 2014; 60(6):716-21. PubMed ID: 25232771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bariatric patients have plasmatic hypercoagulability and systemic upregulation of heme oxygenase activity.
    Nielsen VG; Galvani CA; Boyle PK; Steinbrenner EB; Matika RW
    Blood Coagul Fibrinolysis; 2015 Mar; 26(2):200-4. PubMed ID: 25101516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemeoxygenase-1 mediated hypercoagulability in a patient with thyroid cancer.
    Nielsen VG; Garol BD; Zelman EA; Guerrero MA
    Blood Coagul Fibrinolysis; 2013 Sep; 24(6):663-5. PubMed ID: 23817544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Left Ventricular Assist Device-Associated Carbon Monoxide and Iron-Enhanced Hypercoagulation: Impact of Concurrent Disease.
    Nielsen VG; Sobieski MA; Slaughter MS
    ASAIO J; 2015; 61(4):417-23. PubMed ID: 25710774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heme oxygenase derived carbon monoxide and iron mediated plasmatic hypercoagulability in a patient with calcific mitral valve disease.
    Thompson JL; Nielsen VG; Castro AR; Chen A
    J Thromb Thrombolysis; 2015 May; 39(4):532-5. PubMed ID: 25169134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Redox-based thrombelastographic method to detect carboxyhemefibrinogen-mediated hypercoagulability.
    Nielsen VG; Arkebauer MR; Vosseller K
    Blood Coagul Fibrinolysis; 2011 Dec; 22(8):657-61. PubMed ID: 21822126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tobacco smoke-induced hypercoagulation in human plasma: role of carbon monoxide.
    Nielsen VG; Hafner DT; Steinbrenner EB
    Blood Coagul Fibrinolysis; 2013 Jun; 24(4):405-10. PubMed ID: 23429254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Left atrial myxoma presenting as pulmonary embolism: potential role of heme oxygenase-1.
    Redford DT; Thompson JL; McCulloch JC; Nielsen VG
    Blood Coagul Fibrinolysis; 2014 Sep; 25(6):621-4. PubMed ID: 24553061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of carboxyhemefibrinogen and methemefibrinogen in a patient with thrombosis of a HeartMate II ventricular assist device.
    Smith MC; Nielsen VG
    ASAIO J; 2013; 59(1):93-5. PubMed ID: 23263339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic Migraineurs Form Carboxyhemefibrinogen and Iron-Bound Fibrinogen.
    Nielsen VG; Kulin W; LaWall JS; MacFarland FN; Chen A; Hadley HA; DaDeppo AJ; Steinbrenner EB; Matika RW
    CNS Neurol Disord Drug Targets; 2015; 14(8):1079-85. PubMed ID: 26295816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypercoagulability After Resection of Thoracic Malignancy: A Prospective Evaluation.
    Mulder MB; Proctor KG; Valle EJ; Livingstone AS; Nguyen DM; Van Haren RM
    World J Surg; 2019 Dec; 43(12):3232-3238. PubMed ID: 31407092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased carbon monoxide production by hemeoxygenase-1 caused by device-mediated hemolysis: thrombotic phantom menace?
    Nielsen VG; Pearson EC; Smith MC
    Artif Organs; 2013 Nov; 37(11):1008-14. PubMed ID: 23865494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Iron and Carbon Monoxide on Fibrinogenase-like Degradation of Plasmatic Coagulation by Venoms of Six Agkistrodon Species.
    Nielsen VG; Redford DT; Boyle PK
    Basic Clin Pharmacol Toxicol; 2016 May; 118(5):390-5. PubMed ID: 26467642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thrombelastographic characterization of coagulation/fibrinolysis in horses: role of carboxyheme and metheme states.
    Olver CS; Nielsen VG
    Blood Coagul Fibrinolysis; 2013 Apr; 24(3):273-8. PubMed ID: 23222168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sonoclot(®)-based method to detect iron enhanced coagulation.
    Nielsen VG; Henderson J
    J Thromb Thrombolysis; 2016 Jul; 42(1):1-5. PubMed ID: 26497986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Iron and carbon monoxide prevent degradation of plasmatic coagulation by thrombin-like activity in rattlesnake venom.
    Nielsen VG
    Hum Exp Toxicol; 2016 Oct; 35(10):1116-22. PubMed ID: 26666988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.